IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q4 2016 Holdings

Filed 2017-01-24 | 15 holdings | $18.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anika Therapeutics Inc(ANIK)COM035255108$8.6M175,96746.5%
Charles RIV Labs Intl Inc(CRL)COM159864107$8.5M111,11245.7%
Alphatec Holdings Inc(ATEC)COM NEW02081G201$1.4M426,8557.4%
Supernus Pharmaceuticals Inc(SUPN)COM868459108$13.6K538,2410.1%
Cardinal Health Inc(CAH)COM14149Y108$8.5K117,8000.0%
Amerisourcebergen Corp(COR)COM03073E105$8.4K107,0000.0%
Taro Pharmaceutical Inds LTDSHSM8737E108$8.3K78,9050.0%
Anthem Inc(ELV)COM036752103$8.1K56,3000.0%
Gilead Sciences Inc(GILD)COM375558103$8.1K113,0000.0%
Merck & Co Inc(MRK)COM58933Y105$8.0K136,1000.0%
Mckesson Corp(MCK)COM58155Q103$8.0K57,0000.0%
Triple-S Mgmt Corp(GTS)CL B896749108$7.5K364,1560.0%
Syneron Medical LTDORD SHSM87245102$5.9K706,1070.0%
GNC Hldgs IncCOM CL A36191G107$4.7K422,9550.0%
Immucell Corp(ICCC)COM PAR $0.10452525306$1.0K168,3230.0%